Effects of a beta-blocking agent, timolol maleate, on saliva in healthy volunteers. 1988

K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
Department of Pharmacology, University of Turku, Finland.

The effects of timolol maleate on the secretion and composition of human saliva were studied in vivo. Eight healthy volunteers received orally 10 mg timolol maleate. Stimulated parotid saliva samples, resting whole saliva samples, and blood samples were collected immediately before and four times after the drug intake at intervals of 1 h. The levels of total protein, lysozyme, IgA, IgG and IgM, salivary peroxidase, myeloperoxidase, lactoferrin, amylase, thiocyanate (SCN-), and hypothiocyanite (OSCN-) were analyzed from saliva samples. Drug levels were measured both from parotid saliva and blood samples. Results were compared to the analyses of the samples collected in a similar way but without administration of any drugs. Decreased levels of total protein, lactoferrin, amylase, and salivary peroxidase were observed in parotid saliva after a single oral dose of timolol maleate. No such decrease was found in lysozyme, myeloperoxidase, SCN-, OSCN-, or immunoglobulins. Salivary flow rate was not significantly changed after drug intake. The results suggest that the beta-blocking drug may cause qualitative changes in the composition of saliva by inhibiting the synthesis and/or release of acinar proteins.

UI MeSH Term Description Entries
D007781 Lactoferrin An iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the TYPE III SECRETION SYSTEM used by bacteria to export virulence proteins for host cell invasion. Lactotransferrin
D008297 Male Males
D010544 Peroxidases Ovoperoxidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000681 Amylases A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-. Diastase,Amylase
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D012471 Salivary Proteins and Peptides Proteins and peptides found in SALIVA and the SALIVARY GLANDS. Some salivary proteins such as ALPHA-AMYLASES are enzymes, but their composition varies in different individuals. Salivary Gland Protein,Salivary Gland Proteins,Salivary Peptide,Salivary Protein,Salivary Proteins,Salivary Peptides,Gland Protein, Salivary,Peptide, Salivary,Protein, Salivary,Protein, Salivary Gland
D013999 Timolol A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. (S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol,2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-,Blocadren,L-714,465,MK-950,Optimol,Timacar,Timolol Hemihydrate,Timolol Maleate,Timolol Maleate, (1:1) Salt,Timoptic,Timoptol,L 714,465,L714,465,MK 950,MK950

Related Publications

K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
February 1975, Archives internationales de pharmacodynamie et de therapie,
K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
April 1983, Aviation, space, and environmental medicine,
K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
January 1976, Bulletin des societes d'ophtalmologie de France,
K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
January 1981, Pharmacotherapy,
K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
December 1978, Journal francais d'ophtalmologie,
K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
January 1981, Nippon Ganka Gakkai zasshi,
K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
September 1973, Archives internationales de pharmacodynamie et de therapie,
K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
January 1976, Drug metabolism and disposition: the biological fate of chemicals,
K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
April 1977, Archives of ophthalmology (Chicago, Ill. : 1960),
K Laurikainen, and E Laurikainen, and J Tenovuo, and T Kaila, and P Vilja
January 1989, Epilepsy research,
Copied contents to your clipboard!